Use of cholinesterase inhibitors for treating vascular depression

Details for Australian Patent Application No. 2005215134 (hide)

Owner Novartis AG

Inventors Lane, Roger Michael

Agent Davies Collison Cave

Pub. Number AU-B-2005215134

PCT Pub. Number WO2005/079784

Priority 60/545,871 19.02.04 US

Filing date 18 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 29 January 2009

International Classifications

A61K 31/27 (2006.01)

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/079784 Priority application(s): WO2005/079784

29 January 2009 Application Accepted

  Published as AU-B-2005215134

28 May 2009 Standard Patent Sealed

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005215136-DPP-IV inhibitors for treating neurodegeneration and cognitive disorders

2005215122-Use of meloxicam for the treatment of respiratory diseases in pigs